Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials

Ethical concerns about phase 1 trials persist. Important conceptual advances have been made in understanding concepts used to describe misunderstanding. However, a systematic, empirical evaluation of the frequency of misunderstanding incorporating recent developments is lacking.

[1]  C. Grady,et al.  Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. , 2003, IRB.

[2]  Steven Joffe,et al.  Rethinking risk-benefit assessment for phase I cancer trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Evaluating the Therapeutic Misconception , 2006, Kennedy Institute of Ethics journal.

[4]  M. Ratain,et al.  Perceptions of cancer patients and their physicians involved in phase I trials. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  S. Goodman,et al.  An intervention to improve cancer patients' understanding of early-phase clinical trials. , 2009, IRB.

[6]  J. Lee,et al.  Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  C. Grady,et al.  Patients' decision-making process regarding participation in phase I oncology research. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  K. Weinfurt,et al.  The correlation between patient characteristics and expectations of benefit from Phase I clinical trials , 2003, Cancer.

[9]  E F Cook,et al.  Quality of informed consent: a new measure of understanding among research subjects. , 2001, Journal of the National Cancer Institute.

[10]  P. Appelbaum,et al.  Re-Evaluating the Therapeutic Misconception: Response to Miller and Joffe , 2006, Kennedy Institute of Ethics journal.

[11]  R. Amato,et al.  The association between treatment‐specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial , 2001, Cancer.

[12]  S. Goodman,et al.  What patients say about medical research. , 1998, IRB.

[13]  P S Appelbaum,et al.  False hopes and best data: consent to research and the therapeutic misconception. , 1987, The Hastings Center report.

[14]  J. Aronson,et al.  What is a clinical trial? , 2004, British journal of clinical pharmacology.

[15]  S. Joffe,et al.  Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option? , 2008, Clinical trials.

[16]  S. Rodenhuis,et al.  Patient motivation and informed consent in a phase I study of an anticancer agent. , 1984, European journal of cancer & clinical oncology.

[17]  L. Jansen.  The problem with optimism in clinical trials. , 2006, IRB.

[18]  E. Emanuel,et al.  Ethics of phase 1 oncology studies: reexamining the arguments and data. , 2003, JAMA.

[19]  C. Grady,et al.  Clinical Trials and Medical Care: Defining the Therapeutic Misconception , 2007, PLoS medicine.

[20]  G. Decoster,et al.  Responses and toxic deaths in phase I clinical trials. , 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  C K Daugherty,et al.  Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients. , 2000, IRB.

[22]  K. Weinfurt,et al.  Patient Expectations of Benefit from Phase I Clinical Trials: Linguistic Considerations in Diagnosing a Therapeutic Misconception , 2003, Theoretical medicine and bioethics.

[23]  K. Kieburtz,et al.  Volunteering for early phase gene transfer research in Parkinson disease , 2006, Neurology.

[24]  C. Strong.  How should risks and benefits be balanced in research involving pregnant women and fetuses? , 2011, IRB.

[25]  C. Grady,et al.  Participants in phase 1 oncology research trials: are they vulnerable? , 2008, Archives of internal medicine.

[26]  W. Klein,et al.  Unrealistic optimism in early-phase oncology trials. , 2011, IRB.

[27]  David Wendler,et al.  What Should Research Participants Understand to Understand They are Participants in Research? , 2008, Bioethics.

[28]  L. Fallowfield,et al.  What oncologists believe they said and what patients believe they heard: an analysis of phase I trial discussions. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  K. L. Compton,et al.  Expectations of Benefit in Early-Phase Clinical Trials: Implications for Assessing the Adequacy of Informed Consent , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[30]  K. Itoh,et al.  Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations. , 1997, British Journal of Cancer.

[31]  E. Emanuel.  A phase I trial on the ethics of phase I trials. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  K. Kieburtz,et al.  Trust in early phase research: therapeutic optimism and protective pessimism , 2008, Medicine, health care, and philosophy.

[33]  L. Hawryluck.  People at the end of life are a vulnerable research population. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

[34]  Philip J. Nickel.  Vulnerable Populations in Research: The Case of the Seriously Ill , 2006, Theoretical medicine and bioethics.

[35]  H. Masur,et al.  The impact of disease severity on the informed consent process in clinical research. , 1996, The American journal of medicine.

[36]  M. Ratain,et al.  Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Seiichiro Yamamoto,et al.  Risks and benefits of phase 1 oncology trials, 1991 through 2002. , 2005, The New England journal of medicine.

[38]  P. Appelbaum,et al.  The therapeutic misconception: informed consent in psychiatric research. , 1982, International journal of law and psychiatry.

[39]  C. Daugherty,et al.  Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trials , 2003, Supportive Care in Cancer.

[40]  N. King.  Defining and Describing Benefit Appropriately in Clinical Trials , 2000, Journal of Law, Medicine & Ethics.